E Fund Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$344K Sell
5,849
-7,251
-55% -$304K 0.01% 360
2026
Q1
$422K Buy
+13,100
New +$485K 0.01% 321
2025
Q2
$328K Buy
12,147
+1,776
+17% +$51.4K 0.02% 287
2025
Q1
$308K Buy
10,371
+3,979
+62% +$152K 0.01% 309
2024
Q4
$253K Buy
+6,392
New +$242K 0.01% 337
2024
Q2
Sell
-14,581
Closed -$323K 379
2024
Q1
$323K Buy
14,581
+6,016
+70% +$147K 0.02% 269
2023
Q4
$236K Sell
8,565
-2,348
-22% -$56.7K 0.01% 259
2023
Q3
$244K Sell
10,913
-2,172
-17% -$55.9K 0.02% 228
2023
Q2
$333K Sell
13,085
-3,422
-21% -$83K 0.03% 204
2023
Q1
$368K Buy
16,507
+1,740
+12% +$42.1K 0.03% 197
2022
Q4
$350K Sell
14,767
-8,995
-38% -$209K 0.03% 209
2022
Q3
$394K Buy
23,762
+946
+4% +$21.3K 0.04% 187
2022
Q2
$454K Buy
22,816
+11,540
+102% +$233K 0.04% 162
2022
Q1
$311K Buy
+11,276
New +$323K 0.01% 186

Other funds holding VCYT

E Fund Management's VCYT Position: Q2 2026 in Review

E Fund Management reduced its Veracyte (VCYT) stake by 55% in Q2 2026, selling an estimated $304K and leaving 5,849 shares worth $344K. The position accounts for 0.01% of the portfolio, ranked #360.

E Fund Management first reported a position in VCYT in Q1 2022 and has held it in 14 quarters since. The position peaked at $454K in Q2 2022. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • E Fund Management held 5,849 shares of Veracyte worth $344K as of Q2 2026.
  • E Fund Management sold 7,251 Veracyte shares in Q2 2026, an estimated $304K.
  • Veracyte made up 0.01% of E Fund Management's portfolio in Q2 2026, its #360 holding.
  • E Fund Management first reported a position in Veracyte in Q1 2022 and has held it in 14 quarters since.
  • E Fund Management's Veracyte position peaked at $454K in Q2 2022.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.